$CAPR Pending approval on August 22nd for DERAMIOCEL, for DMD patients. Must see now!
The Adcomm decision did not rule in favor for Capricor Therapeutics $CAPR, on January 29th and there is much debate as to why when DERAMIOCEL works for MANY boys with the rare but debilitating disease of DMD.
I would not be surprised one bit to see accelerated approval immediately once all the shenanigans of the p values are hashed out. I expect full resolution!
God bless all DMD patients on their road to a better and more fulfilling life!
